Skip to main content

Veltin FDA Approval History

FDA Approved: Yes (First approved July 16, 2010)
Brand name: Veltin
Generic name: clindamycin and tretinoin
Dosage form: Gel
Previous Name: Velac
Company: Stiefel Laboratories, Inc.
Treatment for: Acne

Veltin Gel (clindamycin phosphate and tretinoin) is a combination of an antibiotic and a retinoid indicated for the topical treatment of acne vulgaris.

Development timeline for Veltin

DateArticle
Jul 16, 2010Approval Stiefel, a GSK company, Receives FDA Approval of Veltin (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%
Jun 13, 2005Connetics Receives FDA Non-Approvable Letter for Velac
Oct 25, 2004Connetics' New Drug Application for Velac Has Been Accepted for Filing by the FDA

See also

Veltin (clindamycin and tretinoin) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer